- Q1 2024 BioNTech SE Earnings Call TranscriptMay 06, 2024$93.35 (+0.68%)Earnings
- Q4 2023 BioNTech SE Earnings Call TranscriptMar 20, 2024$90 (-4.38%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- BioNTech SE Inaugurates its First African Site in Kigali TranscriptDec 18, 2023
- BioNTech SE Capital Markets Day TranscriptNov 07, 2023
- Q3 2023 BioNTech SE Earnings Call TranscriptNov 06, 2023$99.71 (+4.10%)Earnings
- Q2 2023 BioNTech SE Earnings Call TranscriptAug 07, 2023$98.5 (-7.49%)Earnings
- Q1 2023 BioNTech SE Earnings Call TranscriptMay 08, 2023$108.05 (-0.35%)Earnings
- Q4 2022 BioNTech SE Earnings Call TranscriptMar 27, 2023$123.6 (-3.59%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 BioNTech SE Earnings Call TranscriptNov 07, 2022$160.72 (+4.15%)Earnings
- Q2 2022 BioNTech SE Earnings Call TranscriptAug 08, 2022$169.3 (-7.54%)Earnings
- BioNTech SE To Discuss on Host First Edition of Innovation Series on Diversified Pipeline, Latest Technology Innovations Call TranscriptJun 29, 2022
- Q1 2022 BioNTech SE Earnings Call TranscriptMay 09, 2022$140.32 (+3.05%)Earnings
- Q4 2021 BioNTech SE Earnings Call TranscriptMar 30, 2022$174.78 (+1.39%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 11, 2022
- BioNTech SE To Discuss Hold Digital Press Conference to Provide an Update on Omicron Variant Call TranscriptDec 08, 2021
- Q3 2021 BioNTech SE Earnings Call TranscriptNov 09, 2021$226.37 (-6.69%)Earnings
- Q2 2021 BioNTech SE Earnings Call TranscriptAug 09, 2021$447.23 (+14.97%)Earnings
- BioNTech SE at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- BioNTech SE at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- BioNTech SE at UBS Global Healthcare Virtual Conference TranscriptMay 26, 2021
- Q1 2021 BioNTech SE Earnings Call TranscriptMay 10, 2021$202.35 (+10.15%)Earnings
- BioNTech SE at JPMorgan NAPA Valley Forum (Virtual) TranscriptMar 31, 2021
- Q4 2020 BioNTech SE Earnings Call TranscriptMar 30, 2021$104.44 (+8.89%)Earnings
- BioNTech SE at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 24, 2021
- BioNTech SE at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 BioNTech SE Earnings Call TranscriptNov 10, 2020$112.76 (+7.60%)Earnings
- Q2 2020 BioNTech SE Earnings Call TranscriptAug 11, 2020$68.45 (-7.44%)Earnings
- BioNTech SE To Present Early Positive Data From Ongoing Phase 1/2 Study of mRNA-Based Vaccine Candidate Against SARS-CoV-2 Call TranscriptJul 01, 2020
- BioNTech SE at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- BioNTech SE at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 BioNTech SE Earnings Call TranscriptMay 12, 2020$49.33 (-1.30%)Earnings
- BioNTech SE - Special Call TranscriptApr 23, 2020
- Full Year 2019 BioNTech SE Earnings Call TranscriptMar 31, 2020$58.4 (-5.81%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 BioNTech SE Earnings Call TranscriptNov 14, 2019$19 (+2.43%)Earnings
BioNTech SE To Discuss on Host First Edition of Innovation Series on Diversified Pipeline, Latest Technology Innovations Call Transcript
Good afternoon, good morning. My name is Ryan Richardson. I'm the Chief Strategy Officer of BioNTech, and I'm pleased to welcome you to our first Innovation Series event.
I'm joined here today by my colleagues, Ugur Sahin, our Co-Founder and Chief Executive Officer; Ozlem Tureci, Co-Founder, Chief Medical Officer; and Sierk Poetting, our Chief Operating Officer.
Just a couple of housekeeping items before we get started. The slides that we'll be presenting today can be found in the Investors section of our website. I'd like to remind you that we will be making forward-looking statements. You should not place undue reliance on such statements as actual outcomes could differ from those currently anticipated. For a full description of the risks, both financial and operational. Please refer to our Form 20-F, our annual report, which were filed with the SEC.
We have a full agenda today over the next couple of hours. Very excited to dig deeper into our pipeline, our innovation engine and the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)